ACAD · NASDAQ · Biotechnology

Acadia Pharmaceuticals (ACAD)

Develops NUPLAZID and DAYBUE for neurological and rare diseases.

$26.41
After hours+0.00 (+0.02%)
At close$26.41(+0.04%)
  1. Why Is Acadia (ACAD) Up 0.5% Since Last Earnings Report?

    Zacks Investment ResearchMarket move